Deep Tech Startups

Deep Checks is a curated deal channel that reviews founder pitch decks and forwards the strongest deeptech deals to domain-expert seed-stage VCs, writing a one-pager for each explaining why investors should care. It serves early-stage deeptech founders (hardware, biotech, space, robotics, chips, materials, energy) with valuations of $20M or below and does not take equity or run a program.

1 investor

Deepen AI provides multi-sensor calibration tools and a data lifecycle platform (including data annotation, AI models, and edge optimization) for developers of autonomous vehicles and autonomous systems. It also co-leads Safety Pool, a shared initiative for safety data and standards in autonomous driving, serving enterprises and startups worldwide.

1 investor

Deepentix converts unstructured documents into a verifiable Claim Graph that produces answers with paragraph-level citations and immutable provenance trails for EU-AI-Act compliance. It serves regulated domains such as medical device clinical evaluation, insurance underwriting, legal documentation, and ESG/sustainability, offered as an API-hosted or on-prem product that integrates with ELN/LIMS and claims systems.

1 investor

DeepGate builds energy-efficient machine learning models and a compiler/developer platform for running AI on constrained edge devices such as microcontrollers, smart cameras, audio devices, wearables, and drones. It offers compact vision and audio models plus tooling to compile, benchmark, and deploy models across Arm Cortex-M MCUs from multiple silicon vendors.

1 investor

DeepGreen is a French collaborative project developing Eclipse Aidge, an open-source software platform for designing and deploying embedded/edge AI applications with low energy and memory usage. It brings together French research institutions and industrial partners to serve the French and European industrial ecosystem, focusing on sovereignty, reliability, and frugal AI.

1 investor

Deep Infar provides monitoring and inspection solutions for oil and energy, water management, aquaculture, emergency response, and environmental monitoring applications.

1 investor

deeplify integrates data from inspection, maintenance, and engineering systems to provide AI-powered analysis and risk flagging for integrity engineers in safety-critical industries. The platform connects existing tools without replacement and prepares decisions for human review rather than automating them.

1 investor

Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.

1 investor

Deepnight develops software that uses deep neural networks to turn commodity electro-optical (EO) cameras into low-light night vision, recovering usable imagery in near-total darkness such as moonless starlight. Its technology is applied to defense uses including counter-UAS systems deployed at U.S. Air Force installations.

1 investor

Deep Ocean Capital is an independent venture capital firm focused on investing in deep technology companies. It invests in early-stage ventures developing life-changing technologies across industrial and academic research.

1 investor

DeepSea Technologies develops supervised, human-in-the-loop automation systems for the maritime shipping industry, including propulsion and speed optimization tools that support crew decision-making rather than replace it. Its offerings focus on closing the gap between optimization insights and actual vessel performance.

1 investor

DeepSig develops AI/ML software components and products, including OmniPHY-5G for the 5G RAN and OmniSIG for real-time spectrum awareness, to improve commercial and private wireless communication systems. Its solutions serve telecom operators and security and defense customers by enhancing wireless performance, spectrum sensing, and network security.

1 investor

Deep Tech Marketplace (DTM) is a curated two-day event in Berlin connecting European corporate innovators, investors, and deep tech founders through structured one-on-one matchmaking, pitch competitions, and deal-making programs. It focuses on commercializing deep tech across AI, energy, defence, manufacturing and robotics, space, high-performance computing, and advanced materials.</parameter> <parameter name="hq_city">Berlin

1 investor

Deeptech Labs is a seed-stage venture capital firm and accelerator focused on deep technology companies founded with the University of Cambridge and industry partners including Arm and Cambridge Innovation Capital. The firm invests £100k–£350k in post-seed deep tech startups and runs a structured 10-week programme with expert mentorship and networking to help companies move from prototype to scalable products.

1 investor

A plastic chemical recycling company specializing in advanced recycling technology and plant operations for the circular economy sector.

1 investor

Deeptune builds simulation environments ("training gyms") where AI agents can practice tasks like writing code or working in software such as Slack and Salesforce, then learn and improve over time. The gyms come with problems, datasets, and infrastructure and are targeted at frontier AI research labs.

1 investor

Deepwave Digital designs AI-driven RF, wireless, and edge computing systems for real-time signal classification, detection, and spectrum intelligence. It serves defense, aerospace, telecommunications, government, and research customers with custom silicon, software-defined radio integration, and embedded AI platforms.

1 investor

Deeyook develops firmware-based positioning technology that uses patented wireless interferometry to extract sub-meter location data from existing Wi-Fi signals, working indoors and outdoors without GPS or added hardware. It provides a spatial awareness layer for Physical AI, serving autonomous systems, devices, and connected environments.

1 investor

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

1 investor

Delft Circuits builds Cri/oFlex superconducting cabling that replaces conventional wiring inside cryostats, offering higher channel density and lower thermal load as quantum I/O infrastructure. It designs, manufactures, and validates these systems in-house for the quantum computing industry.

1 investor

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.

1 investor

DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.

1 investor

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types. Its first product targets T-cells to deliver a CAR gene for cancer immunotherapy, with longer-term applications in autoimmune, neurodegenerative, and cardiovascular diseases.

1 investor

Ponce Aurora (deliverthera.com) develops small molecule kinase inhibitors discovered through DNA-encoded library (DEL) screening, including a multi-kinase inhibitor targeting ABL1-T315I and other tyrosine kinases for patients with Ph+ acute lymphocytic leukemia. The company also develops selective JAK/TYK2 inhibitors as senomorphic therapies to regulate the senescence-associated secretory phenotype (SASP) in aging and age-related diseases.

1 investor